About this trial
This study aims to compare the effectiveness of 4mg and 8mg dexamethasone administered submucosally in reducing postoperative pain after dental implant surgery. Participants will be randomly assigned to receive either 4mg dexamethasone, 8mg dexamethasone, or a placebo (normal saline) at the surgical site.
Later, postoperative pain will be assessed using a Visual Analog Scale at 6 hours after the surgery and daily for the next 6 days. Also the number of pain-relief tablets consumed after the surgery will be recorded.
Preoperative anxiety will be assessed using Generalized Anxiety Disorder-7 (GAD-7) questionnaire to assess its association with postoperative pain scores.
The results of this study will help determine the optimal dose of dexamethasone that is effective for postoperative pain control following dental implant surgery.
Eligibility criteria
Qualifiers
Males & females
Age range (21-80)
ASA I & II according to (American Society of Anesthesiologists) classification
Single tooth implant
Disqualifiers
Any known allergy to any medications which will be used in the study
Smokers/ Alcoholics
Pregnant and lactating women
Bone augmentation/ sinus lifting required during the surgery
Trial design
Treatments tested in this trial
- Dexamethasone 4 Mg/mL Injectable Solution
- Dexamethasone 8Mg Solution for Injection
- Saline (NaCl 0,9 %) (placebo)